Research on Glaucoma Diseases

Dear Colleagues,

Glaucoma is a condition with increasing prevalence worldwide, and after cataracts, it is the main cause of visual impairment. Identification of the disease and its etiopathogenesis, as well as its associated risk factors, can enable its early diagnosis and reduce the risk of progression to an irreversible stage in the disease’s development. Open-angle glaucoma, especially secondary open-angle glaucoma, results in large variations in intraocular pressure, and while it is painless, it can lead to significant progression of the disease and markedly impair vision quality. Once the disease has been diagnosed, modern innovations, such as laser therapy or minimally invasive surgery, can be used manage it and to reduce intraocular pressure. In addition, gene therapy is another means of controlling glaucomatous disease.

For this Special Issue, we request original research and reviews that present solutions for the early diagnosis and treatment of glaucoma. This field of research is important, as the pandemic increased the incidence of advanced glaucoma due to the lack of medication despite the continued need for treatment. Topics of interest for this Special Issue include the prediction of glaucoma progression via artificial intelligence tools; gene therapy to control glaucomatous disease; and novel glaucoma devices to reduce glaucoma progression and increase patients' quality of life.

Dr. Nicoleta Anton
Guest Editor

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 250 words) can be sent to the Editorial Office for assessment.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Life is an international peer-reviewed open access monthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2600 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.